Outcome of recipients of human leukocyte antigen incompatible kidney transplants who underwent desensitization at King Fahad Specialist Hospital, Dammam, Saudi Arabia

In patients whom are highly sensitized immunologically, the benefit of kidney transplantation can be extended to this population through the utilization of organs from human leukocyte antigen incompatible (HLAi) donors. This retrospective observational study was designed to identify the incidence an...

Full description

Bibliographic Details
Main Authors: Mohammed Abdulrahim Idris, Akhtar Hossain, Mohammed Abdulrahman Muntasir, Adnan Marmi, Ahmed Abdulfattah Aldajani, Yousef Mohammed Aljamaan, Mahmood Akhtar, Abdulrahman Housawi
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2017-01-01
Series:Saudi Journal of Kidney Diseases and Transplantation
Online Access:http://www.sjkdt.org/article.asp?issn=1319-2442;year=2017;volume=28;issue=3;spage=499;epage=506;aulast=Idris
id doaj-1d32a8853ab749048c6c3f6e5ff90d2a
record_format Article
spelling doaj-1d32a8853ab749048c6c3f6e5ff90d2a2020-11-24T22:55:53ZengWolters Kluwer Medknow PublicationsSaudi Journal of Kidney Diseases and Transplantation1319-24422017-01-0128349950610.4103/1319-2442.206447Outcome of recipients of human leukocyte antigen incompatible kidney transplants who underwent desensitization at King Fahad Specialist Hospital, Dammam, Saudi ArabiaMohammed Abdulrahim IdrisAkhtar HossainMohammed Abdulrahman MuntasirAdnan MarmiAhmed Abdulfattah AldajaniYousef Mohammed AljamaanMahmood AkhtarAbdulrahman HousawiIn patients whom are highly sensitized immunologically, the benefit of kidney transplantation can be extended to this population through the utilization of organs from human leukocyte antigen incompatible (HLAi) donors. This retrospective observational study was designed to identify the incidence and predictors of acute antibody-mediated rejection/acute cellular rejection (AMR/ACR) in our kidney recipients from living kidney donors (sensitized and those with low immunologic risk). This single-center study has been conducted at King Fahad Specialist Hospital, Dammam (KFSH-D), Saudi Arabia; during the period of September 2008- August 2013. All eligible recipients of living donor kidneys during the study period were included (n = 213) in the study. Over 60% of patients in the study were females. Thirty of the 213 kidneys were from HLAi donors. During the follow-up period (median follow-up time = 16 months; 3–27 months), the incidence rate of ACR among HLA compatible (HLAc) and HLAi groups was 22.2% and 16.7%, respectively (P >0.05). The incidence rate of AMR was 2.6% in HLAc group and 16.7%in the HLAi group (P<0.05). The significantly higher incidence of AMR in HLAi group can be explained by the presence of the donor-specific antibodies in weak titers. These results are consistent with studies from similar populations in published literature. However, the relatively small number and short duration of the study are considered, and longer follow-up of this population will be needed for conclusions on the sustainability of our findings.http://www.sjkdt.org/article.asp?issn=1319-2442;year=2017;volume=28;issue=3;spage=499;epage=506;aulast=Idris
collection DOAJ
language English
format Article
sources DOAJ
author Mohammed Abdulrahim Idris
Akhtar Hossain
Mohammed Abdulrahman Muntasir
Adnan Marmi
Ahmed Abdulfattah Aldajani
Yousef Mohammed Aljamaan
Mahmood Akhtar
Abdulrahman Housawi
spellingShingle Mohammed Abdulrahim Idris
Akhtar Hossain
Mohammed Abdulrahman Muntasir
Adnan Marmi
Ahmed Abdulfattah Aldajani
Yousef Mohammed Aljamaan
Mahmood Akhtar
Abdulrahman Housawi
Outcome of recipients of human leukocyte antigen incompatible kidney transplants who underwent desensitization at King Fahad Specialist Hospital, Dammam, Saudi Arabia
Saudi Journal of Kidney Diseases and Transplantation
author_facet Mohammed Abdulrahim Idris
Akhtar Hossain
Mohammed Abdulrahman Muntasir
Adnan Marmi
Ahmed Abdulfattah Aldajani
Yousef Mohammed Aljamaan
Mahmood Akhtar
Abdulrahman Housawi
author_sort Mohammed Abdulrahim Idris
title Outcome of recipients of human leukocyte antigen incompatible kidney transplants who underwent desensitization at King Fahad Specialist Hospital, Dammam, Saudi Arabia
title_short Outcome of recipients of human leukocyte antigen incompatible kidney transplants who underwent desensitization at King Fahad Specialist Hospital, Dammam, Saudi Arabia
title_full Outcome of recipients of human leukocyte antigen incompatible kidney transplants who underwent desensitization at King Fahad Specialist Hospital, Dammam, Saudi Arabia
title_fullStr Outcome of recipients of human leukocyte antigen incompatible kidney transplants who underwent desensitization at King Fahad Specialist Hospital, Dammam, Saudi Arabia
title_full_unstemmed Outcome of recipients of human leukocyte antigen incompatible kidney transplants who underwent desensitization at King Fahad Specialist Hospital, Dammam, Saudi Arabia
title_sort outcome of recipients of human leukocyte antigen incompatible kidney transplants who underwent desensitization at king fahad specialist hospital, dammam, saudi arabia
publisher Wolters Kluwer Medknow Publications
series Saudi Journal of Kidney Diseases and Transplantation
issn 1319-2442
publishDate 2017-01-01
description In patients whom are highly sensitized immunologically, the benefit of kidney transplantation can be extended to this population through the utilization of organs from human leukocyte antigen incompatible (HLAi) donors. This retrospective observational study was designed to identify the incidence and predictors of acute antibody-mediated rejection/acute cellular rejection (AMR/ACR) in our kidney recipients from living kidney donors (sensitized and those with low immunologic risk). This single-center study has been conducted at King Fahad Specialist Hospital, Dammam (KFSH-D), Saudi Arabia; during the period of September 2008- August 2013. All eligible recipients of living donor kidneys during the study period were included (n = 213) in the study. Over 60% of patients in the study were females. Thirty of the 213 kidneys were from HLAi donors. During the follow-up period (median follow-up time = 16 months; 3–27 months), the incidence rate of ACR among HLA compatible (HLAc) and HLAi groups was 22.2% and 16.7%, respectively (P >0.05). The incidence rate of AMR was 2.6% in HLAc group and 16.7%in the HLAi group (P<0.05). The significantly higher incidence of AMR in HLAi group can be explained by the presence of the donor-specific antibodies in weak titers. These results are consistent with studies from similar populations in published literature. However, the relatively small number and short duration of the study are considered, and longer follow-up of this population will be needed for conclusions on the sustainability of our findings.
url http://www.sjkdt.org/article.asp?issn=1319-2442;year=2017;volume=28;issue=3;spage=499;epage=506;aulast=Idris
work_keys_str_mv AT mohammedabdulrahimidris outcomeofrecipientsofhumanleukocyteantigenincompatiblekidneytransplantswhounderwentdesensitizationatkingfahadspecialisthospitaldammamsaudiarabia
AT akhtarhossain outcomeofrecipientsofhumanleukocyteantigenincompatiblekidneytransplantswhounderwentdesensitizationatkingfahadspecialisthospitaldammamsaudiarabia
AT mohammedabdulrahmanmuntasir outcomeofrecipientsofhumanleukocyteantigenincompatiblekidneytransplantswhounderwentdesensitizationatkingfahadspecialisthospitaldammamsaudiarabia
AT adnanmarmi outcomeofrecipientsofhumanleukocyteantigenincompatiblekidneytransplantswhounderwentdesensitizationatkingfahadspecialisthospitaldammamsaudiarabia
AT ahmedabdulfattahaldajani outcomeofrecipientsofhumanleukocyteantigenincompatiblekidneytransplantswhounderwentdesensitizationatkingfahadspecialisthospitaldammamsaudiarabia
AT yousefmohammedaljamaan outcomeofrecipientsofhumanleukocyteantigenincompatiblekidneytransplantswhounderwentdesensitizationatkingfahadspecialisthospitaldammamsaudiarabia
AT mahmoodakhtar outcomeofrecipientsofhumanleukocyteantigenincompatiblekidneytransplantswhounderwentdesensitizationatkingfahadspecialisthospitaldammamsaudiarabia
AT abdulrahmanhousawi outcomeofrecipientsofhumanleukocyteantigenincompatiblekidneytransplantswhounderwentdesensitizationatkingfahadspecialisthospitaldammamsaudiarabia
_version_ 1725656003691675648